Welch & Forbes LLC Acquires 17,481 Shares of Synopsys, Inc. $SNPS

Key Points

• Welch & Forbes LLC nearly doubled its Synopsys stake in the fourth quarter, buying 17,481 additional shares and bringing its total holdings to 35,556 shares valued at about $16.7 million.
• Synopsys reported better-than-expected quarterly results, with EPS of $3.35 versus $3.15 expected and revenue of $2.28 billion, up 41.9% year over year. The company also raised guidance for FY 2026 and Q3 2026.
• Analysts remain mixed but generally constructive: several firms raised price targets, while the overall consensus rating is Hold with a target price of $563.81. Institutional investors still own 85.47% of the stock.

Welch & Forbes LLC lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 96.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,556 shares of the semiconductor company's stock after purchasing an additional 17,481 shares during the quarter. Welch & Forbes LLC's holdings in Synopsys were worth $16,701,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Synopsys during the fourth quarter worth approximately $28,000. Oakworth Capital Inc. boosted its position in shares of Synopsys by 3,700.0% during the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company's stock worth $36,000 after acquiring an additional 74 shares in the last quarter. KERR FINANCIAL PLANNING Corp acquired a new stake in shares of Synopsys during the 3rd quarter worth approximately $38,000. WealthCollab LLC boosted its position in shares of Synopsys by 110.8% during the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company's stock worth $38,000 after acquiring an additional 41 shares in the last quarter. Finally, N.E.W. Advisory Services LLC boosted its position in shares of Synopsys by 128.6% during the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company's stock worth $38,000 after acquiring an additional 45 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

Synopsys Stock Performance

Shares of Synopsys stock opened at $475.62 on Friday. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.26. The firm has a market capitalization of $91.07 billion, a P/E ratio of 110.10, a P/E/G ratio of 3.90 and a beta of 1.25. The company's 50 day moving average price is $459.53 and its two-hundred day moving average price is $454.45.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter last year, the business posted $3.67 earnings per share. The company's quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.28 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on SNPS shares. Piper Sandler increased their price target on shares of Synopsys from $430.00 to $450.00 and gave the stock a "neutral" rating in a research report on Thursday. HSBC lowered shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target on the stock. in a research report on Friday, February 20th. Morgan Stanley increased their price target on shares of Synopsys from $480.00 to $525.00 and gave the stock an "equal weight" rating in a research report on Thursday. Bank of America increased their price target on shares of Synopsys from $515.00 to $600.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, Stifel Nicolaus increased their price target on shares of Synopsys from $550.00 to $600.00 and gave the stock a "buy" rating in a research report on Thursday. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys has a consensus rating of "Hold" and a consensus target price of $563.81.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys said demand for AI chip design software is driving stronger business momentum, and it raised its annual forecast as a result. Synopsys raises annual forecast on demand for AI chip design software
• Positive Sentiment: The CFO highlighted that AI companies are increasingly using custom computer designs, a trend that could expand demand for Synopsys’ chip-design tools. AI Computer Design Diversity A Boon For Synopsys, Says CFO
• Positive Sentiment: Analysts raised price targets after the earnings report, signaling confidence in Synopsys’ longer-term growth outlook despite the stock’s recent weakness. Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
• Positive Sentiment: Synopsys also showcased new AI and multi-die design capabilities with Samsung Foundry, underscoring its role in advanced chip development. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
• Neutral Sentiment: The company beat fiscal Q2 estimates, with revenue up 41.9% year over year and EPS above expectations, but the market still sold the stock after the report. Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus
• Negative Sentiment: Investors appear wary about the company’s chip-IP business and the broader impact of integrating Ansys, which may be weighing on sentiment even after strong results. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.